Market Overview

Neurocrine Biosciences, Inc. (NASDAQ: NBIX)

93.49 0.00 (0.00%)

Analyst Ratings

DateResearch FirmActionCurrentPT
8/07/19RBC CapitalInitiates Coverage OnOutperform118.0
7/30/19Credit SuisseMaintainsOutperform110.0
7/30/19Piper JaffrayMaintainsOverweight111.0
6/05/19GuggenheimInitiates Coverage OnNeutral88.0
5/21/19Credit SuisseInitiates Coverage OnOutperform95.0
4/22/19JP MorganUpgradesOverweight106.0
4/12/19Evercore ISI GroupInitiates Coverage OnOutperform
1/24/19NeedhamDowngradesHold
1/23/19JP MorganDowngradesNeutral100.0
12/13/18Goldman SachsInitiates Coverage OnBuy103.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter